| P2093 | author name string | R. E. Gerner | |
| | W. R. Waddell | |
| | M. P. Reich | |
| P2860 | cites work | A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes | Q24681233 |
| | Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex | Q24681256 |
| | Cancer chemotherapy reports | Q27710278 |
| | Cancer Treatment Reports | Q27710285 |
| | Clinical Research | Q27710467 |
| | British Journal of Pharmacology | Q919631 |
| | Journal of Immunology | Q3521441 |
| | The suppressor-cell network in cancer (first of two parts). | Q33583546 |
| | Indomethacin and ascorbate inhibit desmoid tumors | Q34718386 |
| | Antigen stimulation of prostaglandin synthesis and control of immune responses. | Q34997931 |
| | Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum | Q35062164 |
| | Subversion of immune system by tumor cells and role of prostaglandins | Q35079033 |
| | Cyclic AMP-mediated induction of ornithine decarboxylase of glioma and neuroblastoma cells | Q35085763 |
| | Production of prostaglandins by the pseudopregnant rat uterus, in vitro, and the effect of tamoxifen with the identification of 6-keto-prostaglandin F1alpha as a major product | Q35176874 |
| | Regulation of antibody response by cells expressing histamine receptors | Q36272039 |
| | Immunosuppressive factor(s) specific for L-glutamic acid(50)-L- tyrosine(50) (GT). II. Presence of I-J determinants on the GT-suppressive factor | Q36335652 |
| | The I-J subregion codes for determinants on suppressor factor(s) which limit the contact sensitivity response to picryl chloride | Q36335657 |
| | In vivo effects of anti-Ia alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants | Q36339965 |
| | Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells | Q36346300 |
| | Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid(50)-L-tyrosine(50) induced in BALB/c mice by cyclophosphamide | Q36359648 |
| | Treatment of Intra-abdominal and Abdominal Wall Desmoid Tumors With Drugs That Affect the Metabolism of Cyclic 3', 5'-Adenosine Monophosphate | Q39589669 |
| | Functional Specificity of Thymus-Dependent Lymphocytes | Q39618301 |
| | The involvement of cyclic AMP-dependent protein kinase(s) in the induction of ornithine decarboxylase in the regenerating rat liver and in the adrenal gland after unilateral adrenalectomy | Q40083059 |
| | Regulation of the immune response by prostaglandins | Q40281263 |
| | Cyclic AMP-mediated induction of ornithine decarboxylase in normal and neoplastic growth | Q40283958 |
| | Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin | Q40324395 |
| | Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes | Q40640901 |
| | Ornithine decarboxylase may function as an initiation factor for RNA polymerase I | Q41051139 |
| | Prostaglandin-Producing Suppressor Cells in Hodgkin's Disease | Q41319655 |
| | Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis | Q41364164 |
| | Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle | Q41480581 |
| | Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses | Q41965381 |
| | Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse | Q45076575 |
| | The in vivo stimulation of rat liver ornithine decarboxylase activity by dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline and dexamethasone. | Q54221801 |
| | Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice | Q66885250 |
| | Control of mitogen-induced transformation: Characterization of a splenic suppressor cell and its mode of action | Q66885922 |
| | The induction of ornithine decarboxylase activity and its control in mouse skin epidermis | Q67461853 |
| | The effect of tamoxifen on the in vitro production of prostaglandins F by the guinea pig uterine tissue | Q67555979 |
| | Induction of uterine ornithine decarboxylase (ODC) by antiestrogens. Inhibition of estradiol-mediated induction of ODC: a possible mechanism of action of antiestrogens | Q67811542 |
| | Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF) | Q70524779 |
| | Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model | Q71131291 |
| | Indomethacin-responsive mononuclear cell dysfunction in Hodgkins disease | Q71294741 |
| | Successful tumour immunotherapy with cimetidine in mice | Q72458491 |
| | Cimetidine reduction of tumour formation in mice | Q72458500 |
| | Prostaglandins: fine tuning the immune system? | Q85698190 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | surgery | Q40821 |
| | tamoxifen | Q412178 |
| | oncology | Q162555 |
| P304 | page(s) | 197-211 | |
| P577 | publication date | 1983-03-01 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach | |
| P478 | volume | 22 | |